Role of Mitochondria in Parkinson Disease
暂无分享,去创建一个
[1] J. Montoya,et al. [Diseases of mitochondrial DNA]. , 2000, Revista de neurologia.
[2] M. Graeber,et al. Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson's disease. , 1999, Parkinsonism & related disorders.
[3] P. Vieregge,et al. Parkinson’s disease in twins , 1999, Neurology.
[4] M. Graeber,et al. Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease , 1999, Neurogenetics.
[5] R. Swerdlow,et al. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family , 1998, Annals of neurology.
[6] Y. Agid,et al. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism , 1998, The Lancet.
[7] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.
[8] G. Kroemer,et al. Mitochondria as regulators of apoptosis: doubt no more. , 1998, Biochimica et biophysica acta.
[9] D. Brenner,et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. , 1998, Biochimica et biophysica acta.
[10] J. Cooper,et al. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease , 1998, Annals of neurology.
[11] S. Tabrizi,et al. Mitochondrial DNA in focal dystonia: A cybrid analysis , 1998, Annals of neurology.
[12] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[13] N. Hattori,et al. Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. , 1998, Genomics.
[14] M. Graeber,et al. Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease , 1998, Neurogenetics.
[15] S. Daniel,et al. Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.
[16] Y. Choe,et al. Cloning of the human cDNA sequence encoding the NADH: Ubiquinone oxidoreductase MLRQ subunit , 1997, Biochemistry and molecular biology international.
[17] G. Kroemer,et al. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death , 1997, Oncogene.
[18] M. Graeber,et al. The ‘common deletion’ is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction , 1997, Movement disorders : official journal of the Movement Disorder Society.
[19] M. Graeber,et al. Association of the mitochondrial tRNAA4336G mutation with Alzheimer's and Parkinson's diseases , 1997 .
[20] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[21] G. Wooten,et al. Maternal inheritance in Parkinson's disease , 1997, Annals of neurology.
[22] M. Graeber,et al. On the question of apoptosis in the parkinsonian substantia nigra , 1997, Acta Neuropathologica.
[23] R. Swerdlow,et al. Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.
[24] C. Marsden,et al. Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration. , 1996, Biochemical pharmacology.
[25] Y. Mizuno,et al. Histochemical detection of apoptosis in Parkinson's disease , 1996, Journal of the Neurological Sciences.
[26] D. Wallace,et al. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. , 1996, American journal of medical genetics.
[27] M. Dragunow,et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes , 1995, Neuroreport.
[28] T. Ozawa,et al. Point mutations of mitochondrial genome in Parkinson's disease. , 1995, Brain research. Molecular brain research.
[29] C. Marsden,et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia , 1994, Annals of neurology.
[30] K. Jellinger,et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease , 1994, Neuroscience Letters.
[31] R. Benecke,et al. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. , 1993, Brain : a journal of neurology.
[32] J. Cooper,et al. Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease , 1993, Brain Research.
[33] B. Crain,et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.
[34] L. McMorrow,et al. Multiple chromosomal abnormalities in a case of craniopharyngioma. , 1992, Cancer genetics and cytogenetics.
[35] J. Cooper,et al. Quantitation of a mitochondrial DNA deletion in Parkinson's disease , 1992, FEBS letters.
[36] D. Turnbull,et al. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease , 1991, Journal of the Neurological Sciences.
[37] C. Marsden,et al. Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease , 1990, Journal of neurochemistry.
[38] K. Jellinger,et al. Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect , 1990, Journal of neurochemistry.
[39] K. Ohno,et al. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. , 1990, Biochemical and biophysical research communications.
[40] C. Marsden,et al. Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.
[41] Y. Kagawa,et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.
[42] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[43] F. Sanger,et al. Sequence and organization of the human mitochondrial genome , 1981, Nature.
[44] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[45] E. Zamrini,et al. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. , 1997, The American journal of pathology.
[46] Y. Agid,et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. , 1997, Histology and histopathology.
[47] M. Graeber,et al. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases. , 1997, Neuropathology and applied neurobiology.
[48] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[49] C. Marsden,et al. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. , 1992, Annals of neurology.
[50] A. Duncan,et al. Localization of the human 75-kDal Fe-S protein of NADH-coenzyme Q reductase gene (NDUFS1) to 2q33----q34. , 1992, Cytogenetics and Cell Genetics.
[51] C. Marsden,et al. Mitochondrial function in Parkinson's disease , 1992, Annals of neurology.